Clinical manifestations and treatment outcome of thyrotoxic periodic paralysis

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

TCTR

Registry ID

TCTR20180129001

Enrollment

Unknown

Registered

2018-01-29

Start date

2014-08-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyrotoxic periodic paralysis Thyrotoxic periodic paralysis

Interventions

A retrospective review of the patients with TPP

Other

Thyrotoxic periodic paralysis patients (TPP)

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: The patients were 15 years of age or older who presented with hypokalemia (serum K+ concentration < 3.0 mmol/l) and acute muscle weakness with thyrotoxicosis.

Exclusion criteria

Exclusion criteria: Patients with history of diuretics used, diarrhea or other underlying disease that could caused muscle weakness were excluded.

Design outcomes

Primary

Measure	Time frame
clinical features, laboratory test, treatments and outcome of treatment in Thai TPP patients. During TPP attack and after TPP treatment physical and neurological examination, blood chemistry when TPP was diagnosed and after treatment,	—

Secondary

Measure	Time frame
Hemodynamic (mean arterial pressure and heart rate) changes During surgery standard monitoring (Blood pressure (BP), Pulse rate (PR), Electrocardiography (ECG), end tidal carb	—

Countries

Thailand

Contacts

Public ContactTada Kunavisarut

Mahidol University

kunavisarut@gmail.com0843878300

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026